Literature DB >> 9247129

The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens.

G G Kuiper1, J A Gustafsson.   

Abstract

The recent discovery that an additional estrogen receptor (ER) subtype is present in various rat, mouse and human tissues has advanced our understanding of the mechanisms underlying estrogen signalling. The discovery of a second ER subtype (ERbeta) suggests the existence of two previously unrecognised pathways of estrogen signalling: via the ERbeta subtype in tissues exclusively expressing this subtype and via the formation of heterodimers in tissues expressing both ER subtypes. Various models have been suggested as explanations for the striking cell- and promoter-specific effects of estrogens and anti-estrogens, all on the basis of the assumption that only a single ER gene exists. This minireview describes several of these models and focuses on the potential role which the novel ERbeta subtype might have in this regard.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9247129     DOI: 10.1016/s0014-5793(97)00413-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  73 in total

Review 1.  Estrogen receptor beta in prostate cancer: brake pedal or accelerator?

Authors:  S Signoretti; M Loda
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 2.  Trafficking of peripheral blood CD56(bright) cells to the decidualizing uterus--new tricks for old dogmas?

Authors:  Marianne van den Heuvel; Crystal Peralta; Siamak Bashar; Suzanne Taylor; Julie Horrocks; B Anne Croy
Journal:  J Reprod Immunol       Date:  2005-08-16       Impact factor: 4.054

Review 3.  The role of estrogens and estrogen receptors in normal prostate growth and disease.

Authors:  Gail S Prins; Kenneth S Korach
Journal:  Steroids       Date:  2007-11-12       Impact factor: 2.668

4.  3D-QSAR and docking studies of 3-arylquinazolinethione derivatives as selective estrogen receptor modulators.

Authors:  Aijing Xiao; Zhuoyong Zhang; Liying An; Yuhong Xiang
Journal:  J Mol Model       Date:  2008-01-03       Impact factor: 1.810

5.  Neuroprotective effects of genistein in VSC4.1 motoneurons exposed to activated microglial cytokines.

Authors:  Misty L McDowell; Arabinda Das; Joshua A Smith; Abhay K Varma; Swapan K Ray; Naren L Banik
Journal:  Neurochem Int       Date:  2011-06-06       Impact factor: 3.921

Review 6.  Modulation of transcription factor function by O-GlcNAc modification.

Authors:  Sabire Ozcan; Sreenath S Andrali; Jamie E L Cantrell
Journal:  Biochim Biophys Acta       Date:  2010-03-02

7.  Flexible small molecular anti-estrogens with N,N-dialkylated-2,5-diethoxy-4-morpholinoaniline scaffold targets multiple estrogen receptor conformations.

Authors:  Bethany K Asare; Emmanuel Yawson; Rajendram V Rajnarayanan
Journal:  Cell Cycle       Date:  2017-07-19       Impact factor: 4.534

8.  Anatomical specificity of the brain in the modulation of Neuroglobin and Cytoglobin genes after chronic bisphenol a exposure.

Authors:  Rodrigo Rodrigues da Conceição; Janaina Sena de Souza; Kelen Carneiro de Oliveira; Rui Monteiro de Barros Maciel; Marco Aurélio Romano; Renata Marino Romano; Magnus Régios Dias da Silva; Maria Izabel Chiamolera; Gisele Giannocco
Journal:  Metab Brain Dis       Date:  2017-07-18       Impact factor: 3.584

9.  Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.

Authors:  D K Biswas; L Averboukh; S Sheng; K Martin; D S Ewaniuk; T F Jawde; F Wang; A B Pardee
Journal:  Mol Med       Date:  1998-07       Impact factor: 6.354

10.  The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression.

Authors:  Sandii Brimble; Edith E Wollaston-Hayden; Chin Fen Teo; Andrew C Morris; Lance Wells
Journal:  Curr Signal Transduct Ther       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.